RBC Downgrades Chemours Due to Weak Chemical Demand
RBC Capital Markets downgraded The Chemours Company (CC) from Outperform to Sector Perform, citing ongoing weakness in titanium dioxide demand and challenges within its refrigerants business. The firm also reduced the price target for CC's stock from $22 to $14. Analysts noted that weak chemical demand is impacting performance across key segments of the company. The downgrade reflects concerns over persistent market conditions affecting Chemours' core products, particularly titanium dioxide and refrigerants. These issues are seen as limiting growth potential in what was previously a high-conviction stock for RBC.
Tickers: $CC
Topics: price target cut refrigerants business stock downgrade titanium dioxide demand